Neuraptive Therapeutics

Neuraptive Therapeutics Earns FDA Orphan Drug Designation for Novel Peripheral Nerve Injury Treatment

WAYNE, PA — Neuraptive Therapeutics Inc. recently announced that its novel treatment for peripheral nerve injury, NTX-001, has received Orphan Drug Designation from the United States Food and Drug Administration …

Neuraptive Therapeutics Earns FDA Orphan Drug Designation for Novel Peripheral Nerve Injury Treatment Read More



Centinel Spine

Centinel Spine Reports Record Business Results, Sees Accelerated Growth in Total Disc Replacement Market

WEST CHESTER, PA — Centinel Spine®, LLC, a key player in the medical device industry, recently announced record year-end 2023 business results, laying the groundwork for accelerated growth in 2024. …

Centinel Spine Reports Record Business Results, Sees Accelerated Growth in Total Disc Replacement Market Read More